WRBC
MDCO

W.R. Berkley Corp’s Medicines Co MDCO Stock Holding History

W.R. Berkley Corp’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-118,200
Closed -$10M – 147
2019
Q4 		$10M Buy
+118,200
New +$7.88M 1.83% 18

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

W.R. Berkley Corp's MDCO Position: Q1 2020 in Review

W.R. Berkley Corp sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 118,200 shares — an estimated $10M sold.

W.R. Berkley Corp first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $10M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • W.R. Berkley Corp reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • W.R. Berkley Corp sold 118,200 Medicines Co shares in Q1 2020, an estimated $10M.
  • W.R. Berkley Corp first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • W.R. Berkley Corp's Medicines Co position peaked at $10M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on W.R. Berkley Corp's 13F filing for Q1 2020, filed 15 May 2020.